• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结转移对分化型甲状腺癌初始治疗后甲状腺球蛋白抗体阳性变化的影响。

Effect of Lymph Node Metastasis on Change of Positive Thyroglobulin Antibody in Differentiated Thyroid Carcinoma after Initial Treatment.

作者信息

Zhang Teng, Song Li-Ping, Zhao Teng, Gao Wen, Lin Yan-Song

机构信息

Department of Nuclear Medicine,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.

Department of Imaging and Nuclear Medicine,the First Affiliated Hospital of Jinzhou Medical University,Jinzhou,Liaoning 121001,China.

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Aug 20;39(4):539-543. doi: 10.3881/j.issn.1000-503X.2017.04.013.

DOI:10.3881/j.issn.1000-503X.2017.04.013
PMID:28877833
Abstract

Objective To investigate the influence of lymph node metastasis on the change of positive thyroglobulin antibody(TgAb)in differentiated thyroid carcinoma after initial treatment.Methods We retrospectively analyzed the clinical data of 98 differentiated thyroid carcinoma patients with positive TgAb(≥115 IU/ml)before radioiodine(RAI)therapy.All of whom underwent total or near total thyroidectomy,neck lymph node dissection,and subsequent RAI therapy.Patients were divided into negative group(n=83)and non-negative group(n=15)according to the disappearance of positive TgAb or not after a mean follow-up of 21.0 months.Analysis of variance,χ test,and Mann-Whitney rank-sum test were applied to compare the basic clinical features including number of metastatic lymph nodes,lymph node metastasis rate and node stage,and dose of RAI ablation.The receiver operating characteristic curves were employed to evaluate the predictive values of TgAb levels(negative or positive)and optimal cut-off points.Multivariate analyses were further performed to explore the independent indicators for persistent positive TgAb. Results Compared with the negative group,the proportions of N1a and N1b in the non-negative group were significantly higher,with no N0 in the non-negative group(Fisher's Exact Test,P=0.032).The median metastatic lymph node rate was also significantly higher in the non-negative group(Mann-Whitney U=-3.498,P=0.000).The cut-off value for metastatic lymph node rate to predicting disappearance of positive TgAb was 24%,and its sensitivity was 71.4%.The multivariate analysis showed that only lymph node stage(OR=3.183,P=0.038)was the independent indicator for persistent positive TgAb. Conclusions Lymph node stage was an independent indicator for the disappearance of positive TgAb.A metastatic lymph node rate of higher than 24% may be predictive for the disappearance of positive TgAb.

摘要

目的 探讨分化型甲状腺癌初次治疗后淋巴结转移对甲状腺球蛋白抗体(TgAb)阳性变化的影响。方法 回顾性分析98例放射性碘(RAI)治疗前TgAb阳性(≥115 IU/ml)的分化型甲状腺癌患者的临床资料。所有患者均接受甲状腺全切除或近全切除、颈部淋巴结清扫及后续RAI治疗。平均随访21.0个月后,根据TgAb阳性是否消失将患者分为阴性组(n = 83)和非阴性组(n = 15)。采用方差分析、χ检验和Mann-Whitney秩和检验比较转移淋巴结数量、淋巴结转移率、淋巴结分期及RAI消融剂量等基本临床特征。采用受试者工作特征曲线评估TgAb水平(阴性或阳性)的预测价值及最佳截断点。进一步进行多因素分析以探讨TgAb持续阳性的独立指标。结果 与阴性组相比,非阴性组N1a和N1b的比例显著更高,非阴性组无N0(Fisher确切概率法,P = 0.032)。非阴性组的中位转移淋巴结率也显著更高(Mann-Whitney U = -3.498,P = 0.000)。转移淋巴结率预测TgAb阳性消失的截断值为24%,其敏感性为71.4%。多因素分析显示,仅淋巴结分期(OR = 3.183,P = 0.038)是TgAb持续阳性的独立指标。结论 淋巴结分期是TgAb阳性消失的独立指标。转移淋巴结率高于24%可能预测TgAb阳性消失。

相似文献

1
Effect of Lymph Node Metastasis on Change of Positive Thyroglobulin Antibody in Differentiated Thyroid Carcinoma after Initial Treatment.淋巴结转移对分化型甲状腺癌初始治疗后甲状腺球蛋白抗体阳性变化的影响。
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Aug 20;39(4):539-543. doi: 10.3881/j.issn.1000-503X.2017.04.013.
2
Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.分化型甲状腺癌患者术后抗甲状腺球蛋白抗体的预后价值。
Front Endocrinol (Lausanne). 2024 Apr 24;15:1354426. doi: 10.3389/fendo.2024.1354426. eCollection 2024.
3
Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer.术前抗甲状腺球蛋白抗体对分化型甲状腺癌的预后价值。
Clin Endocrinol (Oxf). 2017 Sep;87(3):292-299. doi: 10.1111/cen.13367. Epub 2017 Jun 8.
4
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.在全甲状腺切除和放射性碘消融治疗后甲状腺癌分化型患者中,抗甲状腺球蛋白抗体阳性且甲状腺功能正常的患者随访期间血清促甲状腺激素升高时,诊断性全身扫描和血清甲状腺球蛋白的价值。
Thyroid. 2012 Feb;22(2):113-6. doi: 10.1089/thy.2011.0020. Epub 2012 Jan 6.
5
[Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].[甲状腺切除术后分化型甲状腺癌患者血清甲状腺球蛋白及抗甲状腺球蛋白抗体的临床意义]
Magy Onkol. 2004;48(1):27-34. Epub 2004 Apr 23.
6
The relationship between BRAFV600E, NF-κB and TgAb expression in papillary thyroid carcinoma.甲状腺乳头状癌中BRAFV600E、核因子-κB与甲状腺球蛋白抗体表达之间的关系
Pathol Res Pract. 2017 Mar;213(3):183-188. doi: 10.1016/j.prp.2016.12.022. Epub 2017 Jan 12.
7
Impact factors for the outcome of the first I radiotherapy in patients with papillary thyroid carcinoma after total thyroidectomy.全甲状腺切除术后乳头状甲状腺癌患者首次碘放疗结局的影响因素。
Ann Nucl Med. 2019 Mar;33(3):177-183. doi: 10.1007/s12149-018-01321-w. Epub 2018 Dec 4.
8
Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.刺激甲状腺球蛋白和预消融抗甲状腺球蛋白抗体产物可预测 TgAb 阳性分化型甲状腺癌患者对放射性碘治疗的反应:一项回顾性研究。
Front Endocrinol (Lausanne). 2023 Sep 22;14:1222470. doi: 10.3389/fendo.2023.1222470. eCollection 2023.
9
Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without I Ablation.全甲状腺切除术后未行 131I 消融治疗的分化型甲状腺癌患者甲状腺球蛋白抗体的变化趋势。
Thyroid. 2018 Jul;28(7):871-879. doi: 10.1089/thy.2018.0080.
10
UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.N1b 期甲状腺乳头状癌患者接受放射性碘治疗的不良反应:一项倾向评分匹配研究。
Endocr Pract. 2019 Dec;25(12):1286-1294. doi: 10.4158/EP-2019-0155. Epub 2019 Aug 14.

引用本文的文献

1
Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer.甲状腺癌术前抗甲状腺球蛋白抗体检测的临床意义。
Korean J Intern Med. 2018 Nov;33(6):1050-1057. doi: 10.3904/kjim.2018.289. Epub 2018 Oct 30.